Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Szabadfi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Molecular Neuroscience : MN|May 1, 2012
Protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degenerationK Szabadfi, B Danyadi, P Kiss, et al.
Journal of Molecular Neuroscience : MN|May 31, 2012
Effects of PACAP on intracellular signaling pathways in human retinal pigment epithelial cells exposed to oxidative stressE Fabian, D Reglodi, L Mester, et al.
Acta Physiologica Hungarica|December 7, 2013
Urocortin 2 treatment is protective in excitotoxic retinal degenerationK Szabadfi, P Kiss, D Reglodi, et al.
Acta Physiologica Hungarica|September 10, 2013
Changes in metabolic and muscle damage indicators following a single bout of jump training on stair versus at levelMárk Váczi, E Tékus, M Kaj, et al.
Neurotoxicity Research|January 8, 2016
Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing PathwayK Szabadfi, D Reglodi, A Szabo, et al.
Neurotoxicity Research|October 25, 2013
Examination of calcium-binding protein expression in the inner ear of wild-type, heterozygous and homozygous pituitary adenylate cyclase-activating polypeptide (PACAP)-knockout mice in kanamycin-induced ototoxicityA Nemeth, K Szabadfi, B Fulop, et al.
Annals of the New York Academy of Sciences|July 17, 2010
Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effectsT Atlasz, K Szabadfi, P Kiss, et al.
Neurotoxicity Research|December 29, 2011
Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient miceA Tamas, K Szabadfi, A Nemeth, et al.
Neurotoxicity Research|July 1, 2011
Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivoK Szabadfi, T Atlasz, P Kiss, et al.
Journal of Molecular Neuroscience : MN|June 1, 2012
PACAP immunoreactivity in human malignant tumor samples and cardiac diseasesZ Szanto, Zs Sarszegi, D Reglodi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Molecular Neuroscience : MN|May 1, 2012
Protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degenerationK Szabadfi, B Danyadi, P Kiss, et al.
Journal of Molecular Neuroscience : MN|May 31, 2012
Effects of PACAP on intracellular signaling pathways in human retinal pigment epithelial cells exposed to oxidative stressE Fabian, D Reglodi, L Mester, et al.
Acta Physiologica Hungarica|December 7, 2013
Urocortin 2 treatment is protective in excitotoxic retinal degenerationK Szabadfi, P Kiss, D Reglodi, et al.
Acta Physiologica Hungarica|September 10, 2013
Changes in metabolic and muscle damage indicators following a single bout of jump training on stair versus at levelMárk Váczi, E Tékus, M Kaj, et al.
Neurotoxicity Research|January 8, 2016
Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing PathwayK Szabadfi, D Reglodi, A Szabo, et al.
Neurotoxicity Research|October 25, 2013
Examination of calcium-binding protein expression in the inner ear of wild-type, heterozygous and homozygous pituitary adenylate cyclase-activating polypeptide (PACAP)-knockout mice in kanamycin-induced ototoxicityA Nemeth, K Szabadfi, B Fulop, et al.
Annals of the New York Academy of Sciences|July 17, 2010
Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effectsT Atlasz, K Szabadfi, P Kiss, et al.
Neurotoxicity Research|December 29, 2011
Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient miceA Tamas, K Szabadfi, A Nemeth, et al.
Neurotoxicity Research|July 1, 2011
Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivoK Szabadfi, T Atlasz, P Kiss, et al.
Journal of Molecular Neuroscience : MN|June 1, 2012
PACAP immunoreactivity in human malignant tumor samples and cardiac diseasesZ Szanto, Zs Sarszegi, D Reglodi, et al.
Pageof 2